S Larsson1, A Struglics2, L S Lohmander3, R Frobell4. 1. Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Lund, Sweden. Electronic address: staffan.larsson@med.lu.se. 2. Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Lund, Sweden. Electronic address: andre.struglics@med.lu.se. 3. Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Lund, Sweden. Electronic address: stefan.lohmander@med.lu.se. 4. Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Orthopaedics, Lund, Sweden. Electronic address: richard.frobell@med.lu.se.
Abstract
OBJECTIVE: Prospectively monitor how treatment of acutely ruptured anterior cruciate ligament (ACL) affects biomarkers of inflammation and proteolytic degradation over 5 years. DESIGN: We studied 119 subjects with acute ACL injury from the randomized controlled knee anterior cruciate ligament, non-surgical versus surgical treatment (KANON)-trial (Clinical trial ISRCTN 84752559) who had synovial fluid, serum and urine samples available from at least two out of six visits over 5 years after acute ACL rupture. All subjects followed a similar rehabilitation protocol where, according to randomization, 60 also had early ACL reconstruction and 59 had the option to undergo a delayed ACL reconstruction if needed. Interleukin (IL)-6, IL-8, IL-10, interferon-gamma (IFNγ), tumor necrosis factor (TNF), amino acids alanine, arginine, glycine, serine (ARGS)-aggrecan, C-terminal crosslinking telopeptide typeII collagen (CTX-II) and N-terminal crosslinking telopeptide type I collagen (NTX-I) were quantified by enzyme-linked immunosorbent assays (ELISA). RESULTS: Subjects randomized to early ACL reconstruction had higher cytokine concentrations in index knee synovial fluid at 4 months (IL-6, IL-8, IL-10, TNF), 8 months (IL-6 and TNF) and at 5 years (IFNγ) compared to those randomized to optional delayed reconstruction. Those that underwent delayed ACL reconstruction within 5 years (30 subjects), had higher synovial fluid concentrations of IL-6 at 5 years compared to those treated with rehabilitation alone. No differences between groups were noted for ARGS-aggrecan in synovial fluid and serum or CTX-II and NTX-I in urine over 5 years, neither as randomized nor as treated. CONCLUSIONS:Surgical ACL reconstruction constitutes a second trauma to the acutely injured joint resulting in a prolonged elevation of already high synovial fluid levels of inflammatory cytokines.
RCT Entities:
OBJECTIVE: Prospectively monitor how treatment of acutely ruptured anterior cruciate ligament (ACL) affects biomarkers of inflammation and proteolytic degradation over 5 years. DESIGN: We studied 119 subjects with acute ACL injury from the randomized controlled knee anterior cruciate ligament, non-surgical versus surgical treatment (KANON)-trial (Clinical trial ISRCTN 84752559) who had synovial fluid, serum and urine samples available from at least two out of six visits over 5 years after acute ACL rupture. All subjects followed a similar rehabilitation protocol where, according to randomization, 60 also had early ACL reconstruction and 59 had the option to undergo a delayed ACL reconstruction if needed. Interleukin (IL)-6, IL-8, IL-10, interferon-gamma (IFNγ), tumor necrosis factor (TNF), amino acids alanine, arginine, glycine, serine (ARGS)-aggrecan, C-terminal crosslinking telopeptide type II collagen (CTX-II) and N-terminal crosslinking telopeptide type I collagen (NTX-I) were quantified by enzyme-linked immunosorbent assays (ELISA). RESULTS: Subjects randomized to early ACL reconstruction had higher cytokine concentrations in index knee synovial fluid at 4 months (IL-6, IL-8, IL-10, TNF), 8 months (IL-6 and TNF) and at 5 years (IFNγ) compared to those randomized to optional delayed reconstruction. Those that underwent delayed ACL reconstruction within 5 years (30 subjects), had higher synovial fluid concentrations of IL-6 at 5 years compared to those treated with rehabilitation alone. No differences between groups were noted for ARGS-aggrecan in synovial fluid and serum or CTX-II and NTX-I in urine over 5 years, neither as randomized nor as treated. CONCLUSIONS: Surgical ACL reconstruction constitutes a second trauma to the acutely injured joint resulting in a prolonged elevation of already high synovial fluid levels of inflammatory cytokines.
Authors: Hope C Davis; Jeffery T Spang; Richard F Loeser; Staffan Larsson; Veronica Ulici; J Troy Blackburn; R Alexander Creighton; Ganesh M Kamath; Joanne M Jordan; Stephen W Marshall; Brian Pietrosimone Journal: Knee Date: 2018-03-07 Impact factor: 2.199
Authors: Armaghan Mahmoudian; L Stefan Lohmander; Ali Mobasheri; Martin Englund; Frank P Luyten Journal: Nat Rev Rheumatol Date: 2021-08-31 Impact factor: 20.543
Authors: Gustavo A Orozco; Atte S A Eskelinen; Joonas P Kosonen; Matthew S Tanaka; Mingrui Yang; Thomas M Link; Benjamin Ma; Xiaojuan Li; Alan J Grodzinsky; Rami K Korhonen; Petri Tanska Journal: J Orthop Res Date: 2021-10-01 Impact factor: 3.102
Authors: Joanna Kvist; Håkan Gauffin; Hanna Tigerstrand Grevnerts; Clare Ardern; Martin Hägglund; Anders Stålman; Richard Frobell Journal: BMJ Open Date: 2018-06-27 Impact factor: 2.692
Authors: F E Watt; N Corp; S R Kingsbury; R Frobell; M Englund; D T Felson; M Levesque; S Majumdar; C Wilson; D J Beard; L S Lohmander; V B Kraus; F Roemer; P G Conaghan; D J Mason Journal: Osteoarthritis Cartilage Date: 2018-08-18 Impact factor: 7.507
Authors: Cale A Jacobs; Caitlin E W Conley; Virginia Byers Kraus; Drew A Lansdown; Brian C Lau; Xiaojuan Li; Sharmila Majumdar; Kurt P Spindler; Nicole G Lemaster; Austin V Stone Journal: Trials Date: 2022-01-31 Impact factor: 2.279